CORRECTED: FDA Commissioner: Action Plans for Shortening Approvals, Sharing Pharmaco Data, Are Coming | GenomeWeb

Note: This article has been corrected from a previous version, which incorrectly stated that McClellan aims to reduce approval time for priority applications to 30 days, and standard application approval time to two months. GenomeWeb regrets the error.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.